WordNet

the 3rd letter of the Roman alphabet (同)c
(music) the keynote of the scale of C major
a general-purpose programing language closely associated with the UNIX operating system

PrepTutorEJDIC

carbonの化学記号
cryの三人称単数現在形
case[s]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 慢性骨髄性白血病の分子遺伝学 molecular genetics of chronic myeloid leukemia
2. 慢性骨髄性白血病に対するチロシンキナーゼ阻害剤の臨床使用 clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia
3. 血液悪性腫瘍およびリンパ悪性腫瘍の遺伝的異常 genetic abnormalities in hematologic and lymphoid malignancies
4. 慢性骨髄性白血病の臨床症状および診断 clinical manifestations and diagnosis of chronic myeloid leukemia
5. 成人におけるフィラデルフィア染色体陽性急性リンパ芽球性白血病に対する導入療法 induction therapy for philadelphia chromosome positive acute lymphoblastic leukemia in adults

English Journal

Abl expression, tumour grade, and apoptosis in chondrosarcoma.

O'Donovan M, Russell JM, O'Leary JJ, Gillan JA, Lawler MP, Gaffney EF.SourceDepartment of Histopathology, St James's Hospital, Dublin, Ireland.
Molecular pathology : MP.Mol Pathol.1999 Dec;52(6):341-4.
AIMS: To determine whether Abl immunoreactivity correlates with grade and cell kinetics (apoptosis and mitosis) in chondrosarcoma.METHODS: Sections from 16 chondrosarcomas were stained immunohistochemically using a polyclonal antibody to the c-Abl/Bcr-Abl oncoprotein. Apoptotic indices and mitotic i
PMID 10748867

Abl expression in human fetal and adult tissues, tumours, and tumour microvessels.

O'Neill AJ, Cotter TG, Russell JM, Gaffney EF.SourceDepartment of Histopathology, St James's Hospital, Dublin, Ireland.
The Journal of pathology.J Pathol.1997 Nov;183(3):325-9.
Abl kinases encoded by the abl oncogenes inhibit apoptosis without affecting cell proliferation. The aim of this study was to examine a wide range of normal fetal and adult human tissues and a variety of tumour types for Abl immunoreactivity. Sections from 193 paraffin blocks of normal fetal and adu
PMID 9422989

Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.

Herrmann F, Jonas D, Helfrich SG, Lindemann A, Schleiermacher E, Mertelsmann R.SourceDepartment of Hematology and Oncology, University of Freiburg, Federal Republic of Germany.
Blut.Blut.1990 Oct;61(4):226-31.
Alpha- and gamma-interferons have been shown to actively suppress hematopoiesis in patients in the chronic phase of chronic myelogenous leukemia in vitro and in vivo. Since both interferons act through different receptors on their hematopoietic target cells, they are expected to be capable of indepe
PMID 2121299

Japanese Journal

Successful Treatment of Chronic Myeloproliferative Disease-unclassifiable (CMPD-U) with No Chromosomal Abnormalities by Imatinib Mesylate

Iyama Satoshi,Matsunaga Takuya,Sato Tsutomu,Murase Kazuyuki,Araki Naoko,Takimoto Rishu,Kobune Masayoshi,Sagawa Tamotsu,Takayama Tetsuji,Niitsu Yoshiro
Internal Medicine 47(8), 791-794, 2008
… Chromosomal and molecular analyses demonstrated no genetic abnormalities of c-abl, bcr-abl, c-kit or platelet-derived growth factor receptor (PDGFR) genes from hematopoietic cells. …
NAID 130000080043

Related Pictures

Nilotinib (AMN107): A Potent Tyrosine Abl Kinase TK fusion protein BCR - ABL Bcr Abl Gene Description Bcr abl STI 1IEP.png Description Bcr abl sti.jpg bcr abl bcr abl phosphorylation of bcr Proteine Protooncogene C-Abl